☰

Shili Xu, Ph.D.

Affiliations: 
2013 Pharmaceutical Sciences University of Southern California, Los Angeles, CA, United States 
Area:
Pharmacy, Oncology
Google:
"Shili Xu"
Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Nouri Neamati grad student 2013 USC
 (Discovery of novel small molecules for ovarian cancer treatment.)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Li R, Ong SL, Tran LM, et al. (2020) Author Correction: Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer. Scientific Reports. 10: 4386
Li R, Ong SL, Tran LM, et al. (2020) Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer. Scientific Reports. 10: 377
Kim SS, Xu S, Cui J, et al. (2020) Histone deacetylase inhibition is synthetically lethal with arginine deprivation in pancreatic cancers with low argininosuccinate synthetase 1 expression. Theranostics. 10: 829-840
Moore AM, Zhou L, Xu S, et al. (2020) Abstract 6045: Interferon signaling induces NAD(H) consumption via PARP9/10/14 and sensitizes pancreatic cancer cells to NAMPT inhibition Cancer Research. 80: 6045-6045
Abt ER, Rosser EW, Durst MA, et al. (2019) Metabolic Modifier Screen Reveals Secondary Targets of Protein Kinase Inhibitors within Nucleotide Metabolism. Cell Chemical Biology
Xu S, Herschman HR. (2019) A tumor agnostic therapeutic strategy for Hexokinase 1 Null/Hexokinase 2 positive cancers. Cancer Research
Xu S, Liu Y, Yang K, et al. (2019) Inhibition of protein disulfide isomerase in glioblastoma causes marked downregulation of DNA repair and DNA damage response genes. Theranostics. 9: 2282-2298
Machiraju PK, Yedla P, Gubbala SP, et al. (2019) Identification, synthesis and evaluation of CSF1R inhibitors using fragment based drug design. Computational Biology and Chemistry. 80: 374-383
Elliott IA, Dann AM, Xu S, et al. (2019) Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion. Proceedings of the National Academy of Sciences of the United States of America
Xu S, Zhou T, Doh HM, et al. (2019) An HK2 antisense oligonucleotide induces synthetic lethality in HK1-HK2+ multiple myeloma. Cancer Research
See more...